Streptococcus pyogenes is the most common bacterial agent implicated in acute tonsillopharyngitis and can also cause a variety of skin and soft tissue infections and severe invasive disease (20) . Macrolides constitute the alternative choice for the treatment of streptococcal tonsillopharyngitis and other respiratory tract infections, valuable especially in patients allergic to ␤-lactams.
Since the late 1990s, resistance to erythromycin and other 14-and 15-membered ring macrolides has been increasingly detected in S. pyogenes in several European countries (1, 10, 16) and other parts of the world, such as Korea (24) . The main known mechanisms of macrolide resistance in S. pyogenes are a 14-and 15-membered ring macrolide-specific efflux mechanism (M phenotype) (21) , encoded by the mef(A) gene (6) , as well as the modification of the ribosomal target by a methylase encoded by the erm(B) (26) or the erm(TR) gene (18) ; the latter is currently referred to as erm(A) or erm(A), subclass erm(TR) gene (17) . Methylation results in reduced binding of and coresistance to 14-, 15-, and 16-membered ring macrolide, lincosamide, and streptogramin B (MLS) antibiotics. Methylase can be expressed either constitutively (cMLS phenotype) or inducibly (iMLS phenotype). Three subtypes of the iMLS macrolide resistance phenotype have been distinguished: iMLS-A, iMLS-B, and iMLS-C (10). Susceptibility to 16-membered ring macrolides was of particular importance in distinguishing these three subtypes. The iMLS-A subtype was characterized by high-level constitutive resistance to 16-membered ring macrolides. In contrast, the iMLS-B and iMLS-C strains were susceptible to the 16-membered ring macrolide josamycin, but after induction they became high-level and low-level resistant, respectively.
Apart from the above, in a few clinical isolates of S. pyogenes, macrolide resistance has been attributed to changes clustered in a highly conserved sequence of L4 (2, 12) and in nucleotide residues of domain V of 23S rRNA (11, 12) , which have a key role in macrolide binding (25) .
Telithromycin is a ketolide developed specifically for the treatment of community-acquired respiratory tract infections. Some of the constitutively resistant erm(B)-positive S. pyogenes isolates were found to be telithromycin resistant, although telithromycin retains activity against strains possessing the other macrolide resistance genotypes, such as erm(A) and mef(A) (10, 16) .
The aim of the present study was to investigate in pharyngeal S. pyogenes isolates recovered from Greek children with acute tonsillopharyngitis over a 4-year study period (i) the phenotypes and genotypes of erythromycin-resistant isolates, (ii) the predominant emm types in erythromycin-susceptible and -resistant isolates, (iii) the in vitro activity of telithromycin in comparison with that of other antibiotics used for the treatment of respiratory tract infections, and (iv) the molecular CTCCTACCTATCC-3Ј and (ii) 5Ј-GTATAAGGGAGCTTGACTG-3Ј and 5Ј-GGGTTTCACACTTAGATG-3Ј. Since better discrimination between mutated alleles was obtained for denatured DNA fragments between 150 and 500 bp, portions of the rrl gene (domains II and V of 23S rRNA), the entire rplV gene and two overlapping fragments of the L4 gene (rplD) were amplified. The three fragments amplified from rrl, two for domain V and one for domain II, included bases that are essential for the development of erythromycin resistance: G2057, A2058, A2062, G2505, C2611, and A752 (4) .
Quinolone resistance determinants. Isolates with reduced susceptibility to ciprofloxacin were tested by PCR for the presence of mutations in the GyrA subunit of the DNA gyrase and/or the ParC subunit of topoisomerase IV.
emm types of S. pyogenes isolates. A randomly selected sample of 104 erythromycin-susceptible and -resistant S. pyogenes isolates were studied for their emm type according to the method of Podbielski et al. (15) . Similarity searching was performed by using the N-terminal hypervariable region of the M gene based on the latest information from the Centers for Disease Control and Prevention website (http://www.cdc.gov/ncidod/-biotech/strep/strains/emmtypes.html). S. pyogenes CS101 (emm 49) was used as a reference strain.
Multilocus sequence typing. Telithromycin-resistant isolates were analyzed by multilocus sequence typing as described by Enright et al. (8) .
Statistical analysis. The standard chi-square test was used for comparison of proportions between groups of isolates, employing Yates' continuity correction in 2 by 2 tables. In the event of low expected frequencies, exact P values were obtained from SPSS version 11 (SPSS Inc., Chicago, Ill). A two-tailed P value of Յ0.05 was considered significant. Resistance to erythromycin was found in 379 (24%) of these 1,577 isolates. Out of a total of 379 erythromycin-resistant isolates, 50.9% had the M phenotype, 0.5% the iMLS-A, 9% had the iMLS-B, 34% the iMLS-C, and finally 5.6% had the cMLS phenotype (Table 1 ). There was phenotype and genotype agreement in Ͼ99% of the erythromycin-resistant isolates. The 379 tested erythromycin-resistant isolates harbored the mef(A) (50.9%), erm(A) (43%), mef(A) plus erm(A) (0.3%), or erm(B) (5.8%) gene ( Table 2) .
RESULTS

Between
The antimicrobial susceptibility results for the 153 randomly sampled erythromycin-susceptible and the 379 erythromycin-resistant isolates are presented in Table 3 . One isolate, not included in the table, had intermediate resistance to erythromycin. The molecular analysis of this isolate did not reveal the presence of any macrolide resistance determinant. The highest rates of reduced susceptibility to Table 3 , good activity against all isolates was seen with cefotaxime (MICs, Յ0.016 g/ml), vancomycin (MICs, 0.125 to 0.5 g/ml), and teicoplanin (MICs, Յ0.03 to 0.25 g/ml). Among the S. pyogenes isolates tested, one had relatively reduced susceptibility to ciprofloxacin (MIC ϭ 2 g/ml) and 22 were telithromycin resistant.
All the isolates that showed the cMLS phenotype and harbored the erm(B) gene had high-level resistance to erythromycin and clindamycin (MICs, Ն32 g/ml), except one isolate that had an erythromycin MIC of 2 g/ml and clinda- mycin MIC of Ն32 g/ml, but was susceptible to telithromycin (MIC, 0.06 g/ml). emm types of S. pyogenes isolates. Three emm types, 1, 2, and 77, accounted for 50% of the 32 typed erythromycin-susceptible isolates (Table 4) . Among the 72 typed erythromycin-resistant isolates, emm 4 (30.6%), emm 28 (22.2%), and emm 77 (12.5%) predominated. emm types 4, 12, 75, and 1 accounted for 86.2% of the mef(A)-positive isolates.
emm type 1 accounted for 8 (25%) of the 32 erythromycinsusceptible isolates and 4 (5.6%) of the 72 erythromycin-resistant strains (P ϭ 0.007). emm type 4 accounted for 2 (6.2%) of the 32 erythromycin-susceptible isolates and 22 (30.6%) of the 72 erythromycin-resistant strains (P ϭ 0.006). emm type 28 was not observed in any of the erythromycin-susceptible isolates compared to 16 (22.2%) of the 72 erythromycin-resistant strains (P ϭ 0.002).
Telithromycin-resistant isolates. In 18 of the 22 telithromycin-resistant isolates, one point mutation was detected in the 23S rRNA (Table 5) . Specifically, a T2136C mutation was present in 15 isolates and a T2166C mutation in three. Sixteen (72.7%) of the 22 isolates showed an identical multilocus sequence type (ST 52) and emm type (emm 28), indicating clonal relatedness of most of the isolates. These 16 isolates were recovered in different areas of the prefecture of Etoloakarnania over a 16-month period.
Isolate with relatively reduced susceptibility to ciprofloxacin. The isolate with the relatively reduced susceptibility to ciprofloxacin had the wild type of the GyrA subunit of the DNA gyrase, whereas a mutation was found in the ParC subunit of topoisomerase IV. Specifically, in regions of the ParC, which determine quinolone resistance, a TCC(S)-79-GCC(A) mutation was detected.
DISCUSSION
Prospectively collecting pediatric tonsillopharyngitis isolates, we were able to create a quite large collection of clinical S. pyogenes isolates from Western Greece over a 4-year period, from 1999 to 2002. One-fourth (24%) of the 1,577 Greek isolates were erythromycin resistant. In Athens, Greece, 15.2% of the S. pyogenes isolates recovered between August 1996 and July 1997 and 23.9% of those isolated between October 1997 and September 1998 were erythromycin resistant (19, 23) .
In this study, the M phenotype was encountered in 50.9% of the erythromycin-resistant isolates. Throughout the 4-year study period, the predominant subtype of the iMLS phenotype was iMLS-C. In the present collection, only two isolates exhibited the iMLS-A subtype; one isolate harbored the erm(A) and the other one the erm(B) gene. Both of the isolates with the iMLS-A subtype have been found to show constitutive resistance to the 16- Resistance to tetracycline appears to be common in the erythromycin-resistant S. pyogenes strains (9, 10). Among the Greek S. pyogenes isolates obtained from 1999 to 2002, variable rates of resistance to tetracycline were associated with the carriage of different macrolide resistance determinants. The highest rate (49.7%) of reduced susceptibility to tetracycline was noted among the isolates carrying the erm(A) gene, whereas the lowest (1.5%) was in strains harboring the mef(A) gene. Concomitant resistance to erythromycin and tetracycline has been attributed to the presence in the same transposon of mef(A), erm(A), or erm(B) gene as well as tet(M) or tet(O) gene encoding resistance to tetracycline (5, 9) .
Our study showed that the erythromycin-resistant isolates belonged to a limited number of emm types. emm types 4, 12, 75, (22) 1 (3.6) 1 (4.5) 0 0 a emm types 3 (n ϭ 1), 6 (n ϭ 1), 15 (n ϭ 1), 27aϭ1/27bϭ2 (n ϭ 1), 44 (n ϭ 1), 49 (n ϭ 1), 65 (n ϭ 1), 68 (n ϭ 1), and [PT 3875(M88)] (n ϭ 1). Sequencing data of telithromycin-resistant isolates showed unique results. In 18 of the 22 isolates one point mutation was detected in the 23S rRNA. Specifically, in 15 isolates a T2136C mutation was detected and in 3 isolates, a T2166C mutation was detected. The T2136C is a new mutation, whereas the T2166C mutation has been described in telithromycin-resistant S. pyogenes isolates recovered in Germany (16) . The relevance between these mutations and the development of macrolide resistance in S. pyogenes needs to be confirmed by further transformation experiments. Most information available today is based on in vitro selection studies showing that certain structures involving domains II and V of 23S rRNA participate in the binding of macrolides (4) . In clinical isolates, most of the point mutations were identical to those found in in vitro selection studies, but new mutations were also observed (11, 12, 16) . The A2058G and A2058U substitutions confer the highest level of MLS resistance (11, 12) .
In summary, 24% of the 1,577 S. pyogenes isolates recovered in Western Greece from 1999 to 2002 were erythromycin resistant. Moreover, 5.8% of the erythromycin-resistant isolates also had resistance to telithromycin. The erythromycin-and telithromycin-resistant isolates showed one of the well-known mutations in the 23S rRNA, but they also exhibited a new mutation in the 23S rRNA. Finally, it should be noted that the Greek S. pyogenes isolates were characterized by the clonal spread of telithromycin resistance.
